Unique ID issued by UMIN | UMIN000000776 |
---|---|
Receipt number | R000000935 |
Scientific Title | Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics |
Date of disclosure of the study information | 2007/08/01 |
Last modified on | 2017/08/02 18:35:38 |
Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics
Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics
Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics
Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics
Japan |
Colorectal tumor with planned elective laparoscopic resection
Infectious disease | Gastrointestinal surgery |
Malignancy
NO
To determine optimal prophylactic antibiotic administration method in elective laparoscopic colorectal surgery
Efficacy
Confirmatory
Pragmatic
Phase III
Incidence and classification of surgical site infection (SSI)
Incidence of colitis, other infectious diseases and other postoperative complications.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
YES
Central registration
2
Prevention
Medicine |
Intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery
2 doses of oral kanamycin(1g)/ metronidazole(750mg) administration on the day before surgery with intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery
20 | years-old | <= |
Not applicable |
Male and Female
Colorectal tumor(cancer, adenoma and suspected cases) with planned elective laparoscopic colorectal resection
1) ECOG Performance Status >=2
2) Age<20
3) Any organ dysfunction
4) Ileus
5) Preoperative infectious disease
6) Antibiotic administration before surgery
7) Steroid administration before surgery
8) Neo-adjuvant radiation and/or chemo therapy
9) Diabetes mellitus
10) Pregnancy/lactational woman
11) Severe allergy
580
1st name | |
Middle name | |
Last name | Hiroaki Hata |
National Hospital Organization, Kyoto Medical Center
Surgery Division
1-1, Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto
075-641-9161
hhata-kyt@umin.ac.jp
1st name | |
Middle name | |
Last name | Hiroaki Hata |
National Hospital Organization, Kyoto Medical Center
Surgery Division
1-1, Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto
075-641-9161
hhata@kyotolan.hosp.go.jp
The Japan-Multinational Trial Organization(JMTO)
None
Self funding
YES
NCT00508690
ClinicalTrials.gov
2007 | Year | 08 | Month | 01 | Day |
Published
https://www.ncbi.nlm.nih.gov/pubmed/26756752
Main results already published
2007 | Year | 05 | Month | 22 | Day |
2007 | Year | 11 | Month | 01 | Day |
2011 | Year | 12 | Month | 31 | Day |
2012 | Year | 04 | Month | 01 | Day |
2012 | Year | 04 | Month | 01 | Day |
2013 | Year | 02 | Month | 28 | Day |
2007 | Year | 07 | Month | 26 | Day |
2017 | Year | 08 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000935